The role of FDG PET/CT radiomics in the prediction of pathological response to neoadjuvant treatment in patients with esophageal cancer.
Michal EiferGregory Peters-FounshteinLotem Cohn YoelHodaya PinianRoee SteinerEyal KlangOnofrio A CatalanoYael EshetLiran DomachevskyPublished in: Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology (2024)
Our findings highlight the potential of FDG PET/CT radiomic features as a predictor for the response to neoadjuvant therapy in esophageal cancer patients. The combination of these radiomic features with select non-radiomic variables provides a model for stratifying patients based on their likelihood to respond to neoadjuvant treatment.
Keyphrases
- rectal cancer
- lymph node
- locally advanced
- end stage renal disease
- ejection fraction
- chronic kidney disease
- stem cells
- squamous cell carcinoma
- prognostic factors
- combination therapy
- magnetic resonance
- risk assessment
- mesenchymal stem cells
- patient reported outcomes
- climate change
- lymph node metastasis
- human health
- smoking cessation
- contrast enhanced